SNORD114-10

RNA & survival
SurvivalRNAKaplan–Meier · TCGA cohorts

Across TCGA pan-cancer cohorts, SNORD114-10 RNA is linked to patient survival in 16 of 34 cancer types, making it the most broadly survival-associated SNORD114-10 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SNORD114-10 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated SNORD114-10 expression acts as an unfavorable survival marker, although some lineages such as GBM and COAD show a favorable association.

KIRC, BRCA, and HNSC are the cancer types where SNORD114-10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.
LineageMeasureSplitStageAUC1
high
AUC2
low
pSampling consensus
KIRCDFSTertileIV0.2190.639<.001129view →
BRCADFSTertileIII,IV0.1730.518<.001117view →
HNSCOSTertileAll0.4170.671.00260view →
MESOOSTertileII,III,IV0.2680.451.00954view →
LUSCDFSTertileII,III,IV0.4910.737.00136view →
READDFSTertileAll0.3360.843.02336view →
SKCMDFSTertileIII,IV0.2080.614<.00121view →
SARCOSTertileAll0.3890.564<.00119view →
ACCOSQuartileAll0.6240.971<.00118view →
LUADOSTertileIV0.1140.560.03818view →
CHOLOSTertileAll0.0890.673.01818view →
GBMOSTertileAll0.3310.234.02413view →
Pink = unfavorable, green = favorable. Showing the 12 strongest of 16 lineages.

Exploration